Sale!

Replica: Osimertinib 3rd Gen EGFR-TKI for NSCLC

Original price was: $605.00.Current price is: $446.00.

Osimertinib, third-generation EGFR-TKI, treats NSCLC with EGFR mutations, including EGFR Ex19Del or EGFR L858R, targets central nervous system metastasis, irreversible inhibition,

SKU: SKU67ELJNWSG Category:
Guaranteed Safe Checkout

Osimertinib, third-generation EGFR-TKI, treats NSCLC with EGFR mutations, including EGFR Ex19Del or EGFR L858R, targets central nervous system metastasis, irreversible inhibition,

Scroll to Top